Related Experiment Videos

An uncommon cause of anaemia in ulcerative colitis

J W van Esser¹, L P Bos, F L Erdkamp

¹Department of Internal Medicine and Gastroenterology, Maasland Hospital, Sittard, Netherlands.

The Netherlands Journal of Medicine

|July 1, 1995

Abstract:

A 56-year-old woman is reported with severe ulcerative colitis who developed a corticosteroid-resistant haemolytic anaemia. The pathogenesis and treatment options in ulcerative-colitis-related haemolytic anaemia are discussed.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Therapeutic drug monitoring in patients with inflammatory bowel disease and established azathioprine therapy.

Clinical drug investigation·2007

Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2006

The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients.

Alimentary pharmacology & therapeutics·2005

The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates.

Annals of hematology·2001

Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.

Blood·2001

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

Blood·2001

See all related articles